Use of botulinum toxin in urology

被引：0

作者：

Jost, W. H. ^{[1
,2
]}

机构：

[1] Deutsch Klin Diagnost, Fachbereich Neurol, D-65191 Wiesbaden, Germany

[2] Deutsch Klin Diagnost, Klin Neurophysiol, D-65191 Wiesbaden, Germany

来源：

NERVENARZT | 2008年 / 79卷

关键词：

botulinum toxin; over active bladder; detrusor-sphincter dyssynergia; urology;

D O I：

10.1007/s00115-006-2154-3

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Botulinum toxin has been used in urology for more than 20 years. Its application, however, has been restricted to merely a few indications because of the lack of approval. Most studies available have focused on disturbed detrusor-sphincter synergy and overactive bladder. Results of a placebo-controlled study on overactive bladder have now been published. Further studies relevant to the approval of botulinum toxin are being conducted. This substance has also been successful in several other urologic indications.

引用

收藏

页码：29 / 32

页数：4

相关论文

共 25 条

[1] Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity [J].

Apostolidis, A ;

Popat, R ;

Yiangou, Y ;

Cockayne, D ;

Ford, APDW ;

Davis, JB ;

Dasgupta, P ;

Fowler, CJ ;

Anand, P .

JOURNAL OF UROLOGY, 2005, 174 (03) :977-982

[2] Novel action of botulinum toxin on the stromal and epithelial components of the prostate gland [J].

Chuang, YC ;

Huang, CC ;

Kang, HY ;

Chiang, PH ;

Demiguel, F ;

Yoshimura, N ;

Chancellor, MB .

JOURNAL OF UROLOGY, 2006, 175 (03) :1158-1163

[3]

Doggweiler R, 1998, PROSTATE, V37, P44

[4]

DYKSTRA DD, 1990, ARCH PHYS MED REHAB, V71, P24

[5] EFFECTS OF BOTULINUM A TOXIN ON DETRUSOR-SPHINCTER DYSSYNERGIA IN SPINAL-CORD INJURY PATIENTS [J].

DYKSTRA, DD ;

SIDI, AA ;

SCOTT, AB ;

PAGEL, JM ;

GOLDISH, GD .

JOURNAL OF UROLOGY, 1988, 139 (05) :919-922

[6] Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patients [J].

Gallien, P ;

Reymann, JM ;

Amarenco, G ;

Nicolas, B ;

de Sèze, M ;

Bellissant, E .

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76 (12) :1670-1676

[7]

Jost WH, 1998, UROLOGY, V52, P352

[8]

JOST WH, 1999, J NEUROL, V246, P89

[9]

JOST WH, 1995, MOVEMENT DISORD, V10, P404

[10] Cost-consequence analysis evaluating the use of botulinum neurotoxin-A in patients with detrusor overactivity based on clinical outcomes observed at a single UK centre [J].

Kalsi, V ;

Popat, RB ;

Apostolidis, A ;

Kavia, R ;

Odeyemi, IAO ;

Dakin, HA ;

Warner, J ;

Elneil, S ;

Fowler, CJ ;

Dasqupta, P .

EUROPEAN UROLOGY, 2006, 49 (03) :519-527